BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28566437)

  • 1. Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas.
    King AR; Corso CD; Chen EM; Song E; Bongiorni P; Chen Z; Sundaram RK; Bindra RS; Saltzman WM
    Mol Cancer Ther; 2017 Aug; 16(8):1456-1469. PubMed ID: 28566437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.
    Chen EM; Quijano AR; Seo YE; Jackson C; Josowitz AD; Noorbakhsh S; Merlettini A; Sundaram RK; Focarete ML; Jiang Z; Bindra RS; Saltzman WM
    Biomaterials; 2018 Sep; 178():193-203. PubMed ID: 29936153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
    Gwak HS; Park HJ
    Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
    Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
    J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.
    Zhou Z; Singh R; Souweidane MM
    Curr Neuropharmacol; 2017; 15(1):116-128. PubMed ID: 27306036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas.
    Caretti V; Hiddingh L; Lagerweij T; Schellen P; Koken PW; Hulleman E; van Vuurden DG; Vandertop WP; Kaspers GJ; Noske DP; Wurdinger T
    Mol Cancer Ther; 2013 Feb; 12(2):141-50. PubMed ID: 23270927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.
    Pal S; Kozono D; Yang X; Fendler W; Fitts W; Ni J; Alberta JA; Zhao J; Liu KX; Bian J; Truffaux N; Weiss WA; Resnick AC; Bandopadhayay P; Ligon KL; DuBois SG; Mueller S; Chowdhury D; Haas-Kogan DA
    Cancer Res; 2018 Jul; 78(14):4007-4021. PubMed ID: 29760046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.
    Karlin J; Allen J; Ahmad SF; Hughes G; Sheridan V; Odedra R; Farrington P; Cadogan EB; Riches LC; Garcia-Trinidad A; Thomason AG; Patel B; Vincent J; Lau A; Pike KG; Hunt TA; Sule A; Valerie NCK; Biddlestone-Thorpe L; Kahn J; Beckta JM; Mukhopadhyay N; Barlaam B; Degorce SL; Kettle J; Colclough N; Wilson J; Smith A; Barrett IP; Zheng L; Zhang T; Wang Y; Chen K; Pass M; Durant ST; Valerie K
    Mol Cancer Ther; 2018 Aug; 17(8):1637-1647. PubMed ID: 29769307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma.
    Chornenkyy Y; Agnihotri S; Yu M; Buczkowicz P; Rakopoulos P; Golbourn B; Garzia L; Siddaway R; Leung S; Rutka JT; Taylor MD; Dirks PB; Hawkins C
    Mol Cancer Ther; 2015 Nov; 14(11):2560-8. PubMed ID: 26351319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies.
    Frazier JL; Lee J; Thomale UW; Noggle JC; Cohen KJ; Jallo GI
    J Neurosurg Pediatr; 2009 Apr; 3(4):259-69. PubMed ID: 19338403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
    Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
    J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.
    Guisado DI; Singh R; Minkowitz S; Zhou Z; Haque S; Peck KK; Young RJ; Tsiouris AJ; Souweidane MM; Thakur SB
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1367-73. PubMed ID: 26939629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELK Inhibition in Diffuse Intrinsic Pontine Glioma.
    Meel MH; de Gooijer MC; Guillén Navarro M; Waranecki P; Breur M; Buil LCM; Wedekind LE; Twisk JWR; Koster J; Hashizume R; Raabe EH; Montero Carcaboso A; Bugiani M; van Tellingen O; van Vuurden DG; Kaspers GJL; Hulleman E
    Clin Cancer Res; 2018 Nov; 24(22):5645-5657. PubMed ID: 30061363
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
    Broniscer A; Jia S; Mandrell B; Hamideh D; Huang J; Onar-Thomas A; Gajjar A; Raimondi SC; Tatevossian RG; Stewart CF
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27035. PubMed ID: 29512900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy.
    Hua L; Wang Z; Zhao L; Mao H; Wang G; Zhang K; Liu X; Wu D; Zheng Y; Lu J; Yu R; Liu H
    Theranostics; 2018; 8(18):5088-5105. PubMed ID: 30429888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery methods of therapeutic agents in the treatment of diffuse intrinsic brainstem gliomas.
    Goodwin CR; Xu R; Iyer R; Sankey EW; Liu A; Abu-Bonsrah N; Sarabia-Estrada R; Frazier JL; Sciubba DM; Jallo GI
    Clin Neurol Neurosurg; 2016 Mar; 142():120-127. PubMed ID: 26849840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.
    Liu H; Cai Y; Zhang Y; Xie Y; Qiu H; Hua L; Liu X; Li Y; Lu J; Zhang L; Yu R
    Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.